constitutional drama behind significant supreme court decisions and for the next several weeks, watch key episodes from our series. sunday on c-span, then 1919 case that allowed the government in times of war to limit freedom of speech. the court upheld the conviction of the activist who distributes that she distributed leaflets urging young men to resist the draft -- activist who distributed leaflets urging young venture business the draft. >> today, the white house covid-19 response team announced plans to share 25 million vaccine doses with the world. the response team also provided an update on the number of covid-19 cases in the u.s.. >> good morning and thank you for joining us. i will begin with an update both

on our domestic and global efforts to defeat covid-19. we have with us the national security advisor, jake sullivan, who will join me and speaking about our next steps in our global covid-19 response, then dr. walensky will give an update on the state of the pandemic and dr. fauci will discuss the latest lands. we believe some time for q&a at the end. on his first full day in office, president biden released a comprehensive strategy to marshall ebola government more time effort to defeat the pandemic. we have spent each and every day at the last 4.5 months executing against that strategy and today, i want to provide an update on the progress we are making. first, on our efforts to get americans vaccinated as quickly, efficiently, and equitably as possible. second, on our efforts to help combat the pandemic globally.

here at home, we have built a best in class vaccination program, already 63% of adult americans have received at least one shot and 52% of adult americans are fully vaccinated. 12 states have 70% of adults with at least one shot. that is an important milestone. 28 states and the district of columbia have fully vaccinated 50% or more of their adult population. as a result, in communities and states across the country the , pandemic is in retreat. since the president took office january 20, cases are down 90%. deaths are down 85%. our successful vaccination program is not just saving tens of thousands of lives, it is letting tens of millions of americans get back to living

their lives. it is fair to say that we are far ahead where anyone thought we would be in our fight against the virus. importantly, we have secured enough vaccine supply for all americans. this is a direct result of the president taking aggressive action, including through the use of the defense production act to mobilize the full force of u.s. vaccine manufacturing and production. because of those actions and the success of vaccine manufacturers, we are confident in our supply of authorized vaccines. as a result, we are moving the dpa priority ratings for astrazeneca, novavax, and some of. while manufacturers will continue to make these vaccines, this will allow u.s.-based manufacturers to make their own

decisions about which orders to fulfill first. for all of the progress we have made as a country, as the president reiterated this afternoon, we have millions of americans and need of protection and communities are at risk because of low vaccination rates. here's the bottom line, if you are unvaccinated, you are still at risk of getting seriously ill or spreading the disease to others. to help get as many people vaccinated as we can, we are kicking off a month of action , mobilizing an all of america effort, including new commitments to childcare providers to provide free, drop in childcare to allow parents to get vaccinated. extended hours at local pharmacies for vaccinations, including many pharmacies that will be open 24 hours every friday starting next week. commitments from the state and private sector to privatize vaccinations and celebrate our progress, including free beer

for anyone over the age of 21 on july 4, courtesy of anheuser-busch. the vice president is leading a "we can do this" vaccination tour. this national vaccination tour to key communities across the country will help reach millions of americans who still need protection against the virus, highlight the ease of getting vaccinated, encourage vaccination, and energize and mobilize grassroots vaccine education and outreach efforts. as the days get brighter and brighter at home, we are focused on driving progress to help the pandemic -- help end the pandemic around the globe. it is both the right thing to do and an important step in protecting americans by helping to stamp out the virus. the president has committed that the u.s. will be an arsenal of vaccines. our work on vaccine supply is guided by a three-part approach.

first, having successfully secured enough supply of vaccine for americans, we are donating surplus u.s. vaccine supply and encouraging other countries with surplus supplies to do the same. in march, the u.s. shared over 4 million doses of our astrazeneca vaccine supply with canada and mexico. the president has announced the u.s. commitment to share a total of 80 million doses by the end of june. this is five times the number of doses any other country is committed to sharing. these 80 million doses represent 13% of the total vaccines produced by the united states by the end of this month. we will continue to donate additional doses across the summer months as supply becomes available. at the same time, we know that won't be sufficient.

the second part of our approach is working with u.s. vaccine manufacturers to vastly increase the vaccine supply for the rest of the world in a way that also creates jobs here at home. driven by the actions that have been taken to accelerate manufacturing and production in the u.s., pfizer and moderna have increased their capacity to produce vaccines for the world. the third part of our approach will have us work with our partner nations and pharmaceutical companies and other manufacturers to facilitate the kind of global vaccine manufacturing and production capacity and capabilities that cannot only help the world beat this pandemic, but also prepare the world to respond to potential future threats. today, we are outlining our framework for sharing with the world the first 25 million doses. to be clear, our approach to ensure vaccines are delivered in a way that is equitable and

follows the latest science and public health data. across the coming weeks, the administration will move as expeditiously as possible and work through reg of the toray requirements and logistical details to ensure safe and secure delivery of doses. this is a complex operational challenge but one that we take on and will get done. less than two weeks ago, the president committed to providing one million doses of the johnson & johnson vaccine to the republic of korea. after making the 2000 mile journey to california, these one million doses are being loaded into a plane that will take off to the republic of korea this evening, carrying hope and bringing lifesaving protection to the one million south koreans who have already signed up to get a shot. this is just the beginning. we expect a regular cadence of shipments around the world across the next several weeks. in the weeks ahead, working with

the world's democracies, we will coordinate a multilateral effort including through the g7 to combat the pandemic. now let me turn over to jake sullivan. jake: today, we are announcing our plan for sharing the first 25 million u.s. vaccines with the world. i am going to brief the outline why we are saying them, how we are sharing them, and where we will share them. first, our goal in sharing our vaccines is in service of ending the pandemic globally. our overarching aim is to get as many safe and effective vaccines to as many people as possible as fast as possible. it is as simple as that. we want to save lives. perhaps most important, this is the right thing to do thanks to the ingenuity of american scientists and the resilience

and commitment to the american people, we are in a position to help others so we will help others. as the president has said, the united states will not use its vaccines to secure favors from other countries. next, i want to say little about how we are sharing. we have received requests from all over the world and a number of important factors went into our decision about how to allocate these first 25 million vaccines. these included achieving global coverage, responding to surges and other urgent situations in public health needs, and helping as many countries as possible who requested vaccines. we have also decided to prioritize helping our neighbors. we made the decision to share at least 75% of these vaccines through covax. this will maximize the number of vaccines available equitably for all countries and will

facilitate sharing with those most at risk. and we decided to share up to 25% of these vaccines for immediate needs and to help with surges around the world. we can share these 25% in a flexible way. finally, i want to talk about where we are sharing these first 25 million doses. we are sharing them in a wide range of countries within latin america and the caribbean, south and southeast asia, and across africa in coronation with the african union. this includes prioritizing our neighbors in our hemisphere, including countries like guatemala and columbia, peru and ecuador, and many others. it respects existing regional networks for vaccine sharing like the platform of the african union and african centers for disease control and prevention and the regional health agency in the caribbean. these networks will help decide where to allocate needed doses in regions with low vaccination

rates and to those most at risk, including health care workers who have not yet gotten their shots. our approach also prioritizes south and southeast asia, including countries like india, nepal, the philippines, and others that are undergoing surges right now. it recognizes our neighbors, canada and mexico, which received our first shared vaccines. and friends like the republic of korea, where our military shares the command. it prioritizes other partners around the world, including countries with low vaccination rates who are dealing with urgent present crises, like the west bank in gaza, ukraine, cozumel, iraq, haiti, and others. in the days ahead, we will coordinate closely with covax and countries that will receive our vaccines. as jeff has said, this is only the beginning. the president has committed to

sharing doses on an ongoing basis, starting with 80 million by the end of june. we will continue to donate from our excess supply as that supply is delivered to us. we will work with our international partners to get ahead of the virus, to follow the science, and help countries in crisis. we also know this will not be enough to end or reduce the lifespan of the pandemic. that is why we are working with allies and partners to expand the production of vaccines and raw materials, including here at home, as jeff described, and by building capacity around the world. we are also working with our g7 partners on a larger effort to help end the pandemic so that the world's democracies deliver for people everywhere. we will have more to say about this next week when the g7 leaders meet in the u.k. we will continue to build on our existing health and health security efforts focused on stopping the spread of covid-19, increasing vaccination,

detecting outbreaks and variants, responding to flares, and critically recovering economically here at home and around the world. and we will do so in a way that strengthens our health institutions and our ability to come together as an international community to defeats not just this pandemic but the next one and the one after that. as president biden said in may, this is a unique moment in history and it requires american leadership, american science and ingenuity, american perseverance, and the world's democracies to step up to the plate. today, i am proud to say that effort is underway. thanks. jeff: now over to dr. walensky. dr. walensky. dr. walensky: good morning, it is great to be back with you. let's begin with an overview of the data. yesterday, cdc reported little over 9003 hundred new cases of covid-19.

our 7 day average is extinct cases per day. this represents a decrease of more than 30% from our prior 7 day average and it is a 94% decrease from the peak of covid-19 cases reported in january this year. this is the type of news i like to deliver and this data is encouraging as we battle this pandemic. the 7 day average of new hospital admissions is about 2750, a decrease of 83% in hospitalizations since january 9 this year where we peaked at a 7 day average of 16,500 daily hospital admissions. we can agree these trends are going in the right direction. the 7 day average of daily deaths has also declined to a new low of 363 per day, a decrease of more than 16% since last week. as the administration kicks off its national month of action in

the critical month of june, i want to highlight a specific population we are hoping will join the tens of millions who have already been vaccinated. that is adolescents. in the months leading up to the recommendations of the pfizer vaccines for teens and adolescents 12 and older, the cdc observed troubling data regarding the hospitalizations of adolescents with covid-19. more concerning were the number of adolescents admitted to the hospital who required treatment in the intensive care unit with mechanical ventilation. tomorrow, we will publish a report with more details along with the mortality report. it is these findings within this publication, one that demonstrates the level of severe disease even among youth that are preventable, that force us to redouble our motivation to get our adolescents and young adults vaccinated. last month, the fda authorized and the cdc recommended a safe and effective vaccine for covid-19 that can be used in

adolescents to prevent disease and hospitalization. i strongly encourage parents to get their teens vaccinated as i did mine. if parents have questions or concerns, talk with your child's health care provider, your local department of public health or local pharmacist. until teens are fully vaccinated, they should continue to wear masks and take precautions when around others who are not fully vaccinated to protect themselves, their friends, families, and community. dr. fauci: i would like to spend a minute or so updating you in the arena of selected covid-19 therapeutics. i don't know if you can see the slide, but the first slide that says selected therapeutics is broken up into three major components just to remind you that the work that has been done over the past many months has been three separate approaches. one is to target the virus

itself. as you can see, the number of interventions are listed there. the other is to moderate a n inflammatory response, moderating the host. the others are therapies such as anticoagulants. if you can move to the next slide which has the red circle around the third bullet, that is what i want to bring to the attention of the audience. that is monoclonal antibodies, two of which, the regeneron combination and the eli lilly combination, have been approved. i highlighted in blue an additional antibody made by gsk and vir. if you go to the next slide, six days ago, some very interesting and exciting data has been published. that is a randomized placebo-controlled phase three trial of non-hospitalized patients with mild to moderate

covid-19 who are at high risk for the progression of their disease, close to 600 people, a single 500 milligram dose of the monoclonal antibody by gsk and vir reduced the risk of hospitalization or death by 85% compared with the placebo. it is well tolerated and there are no safety signals identified. in the test tube, the antibody retains activity against multiple variants. what we really have now are three options within the arena of monoclonal antibodies, something that is important for physicians to know that there is an important option for treating people early to prevent them from going to the hospital. this has been granted an eua so

it is available for use and we encourage physicians to at least consider this possibility as part of your therapeutic. i will stop there and back to you, jeff. jeff: thank you. why don't we open it up for a few questions. >> we are running short on time so we will just take a couple of questions. please keep to just one question and on topic. first, josh of bloomberg. >> thank you. can you hear me? jeff: i can hear you, josh. >> great. can you speak to which specific vaccines will be sent in the 25 million? i assume it is safe to say that the astrazeneca doses remain under review? jeff: i think we are working on some technical issues and hopefully we are able to open up

for questions soon. >> jeff, let me know if you can hear me, please. jeff: yes. >> i was just wondering if you could say which vaccines will be sent among the 25 million. i assume astrazeneca doses remain under review and are not available? jeff: good question. thank you for the question. that is correct. the astrazeneca doses, the 60 million doses are awaiting fda conference. so the 25 million will be comprised of the three approved , authorized vaccines, a combination of johnson & johnson, pfizer, and moderna. next one. >> thanks so much, jeff.

my question is, does the u.s. still have a final say where doses go, or is it covax picking a decision? when will these 25 million be distributed and are you confident the remaining 55 will be out by the end of june? jeff: jake, why don't i hand it to you. jake: where the vaccines go, jeff, was that the question? jeff: yes. the question on covax, if you can handle that and i will take -- i will handle the second piece. jake: we may have some auto issues, but -- some audio

issues, but as i understand, the question is if the u.s. has the final say on where the doses are going shared through covax. the answer is that the u.s. working with covax has taken a list of countries. the doses that are allocated to each of those countries and we have made selections against that list. so that we will retain the say in terms of where they go. in the case of the african union, we are sharing with the african union, who will ultimately be making the determinations about how to allocate within africa. in the case of the caribbean, we will be working with the public health authority in the caribbean, who will be making some of the key determinations for where the doses are allocated. ultimately, the u.s. will have the authority to say that the doses are going here as opposed to there. that will be done in close consultation with covax and

according to covax's formula and then using the covax logistics capacity and delivery capacity to ensure these doses translate into shots in arms that help save people's lives. jeff: the second part of the question -- [indiscernible] those doses are in flight now. we announced plans to share about 13% of the vaccines produced for the u.s. by the end of june. that is the most of any nation. over the coming weeks, we will work to get those doses to countries and get shots in arms as soon as possible. as we do so, we will work through logistics like medical agencies coordinating to ensure safety and regulatory information to share supply, to make sure we have the necessary

needles and syringes and alcohol pads. transportation teams to ensure proper temperature storage, prevent breakage, and make sure the vaccine immediately clears customs. the process to export the first 35 million is underway in association with foreign governments. the president has committed to sharing 80 million doses by the end of june and we will deliver on the president's commitment by the end of june. >> sorry for the technical challenges. cheryl at the new york times. >> thank you for taking my call. i wondered if you could be more specific about the 25% of doses you are reserving for immediate use, the flexible doses. where are those going? jeff: over to jake.

jake: technical difficulties persist, but the answer is that we will lay out more specifically the precise destination of those. the judgment we make about where those go is a combination of where there are urgent situations or where partner countries are facing crises. some examples of that include -- a portion of those will go to india, which has obviously dealt with a surge. we have seen the gripping images coming from that country. some of them will go to the west bank and gaza, which has endured

its own form of crisis. there will be other destinations for the remaining doses. we will lay that out as those doses are prepared and shipped. jeff: next question. >> we will do one more question to zeke at ap. >> thank you. can you say where the doses are coming from? are they coming from states' inventory or the approval of federal supply? for jake, can you explain how the president's guidance that there will be no strings attached to these vaccines -- [indiscernible] why not just give it all to covax to be shared?

jeff: on the first question, the 25 million doses are coming from the federal pool of supply. the doses that are at the states levels, those states have ordered those so we are working to administer shots in arms so the millions of americans who have not been vaccinated can get vaccinated as soon as possible. jake: the united states is not asking anything of any country to whom we are giving doses. we are not seeking to extract concessions, we are not extorting, we are not imposing conditions the way other countries who are providing doses are doing. we are doing none of those things. these are doses being donated free and clear to these countries for the sole purpose of improving the public health situation. the korea situation is unique because the president said that when president moon visited, the

animating purpose behind that is actually about the protection of american forces on the forces who serve alongside american forces, the korean troops standing shoulder to shoulder with us in that country. it is a unique case and the kind of unique case for which we went to we can flexibility, which is why we are giving 75% or more of our doses through covax, but maintaining the capacity to allocate doses outside the covax formula as necessary. korea is one case of that. the west bank and gaza is another case, where we are not asking anything of the people of gaza or the west bank. we feel given what they are dealing with in the situation on the ground, it is only right and proper and good for the united states to allocate some doses to that country. the same is true with some of the other allocations we will make. the president made a commitment to ensure india received doses, giving them not just an

allocation under the regional portion of this, but an additional allocation from our discretionary portion. it is something he wanted to do. again, the basic bottom line is that the u.s. is not doing this as some kind of back and forth deal where we are getting from -- we are getting something from what we are giving. we are giving these for a single purpose. it is the purpose of ending this pandemic and we are doing so in a way consistent with the public health requirements that will help hasten the end of the covid-19 pandemic. jeff: we have time for one more. >> all right, let's keep going. let's go to cbs. >> thank you so much.

my question is for dr. wilensky. as you launch this push for vaccinations ahead of july 4, this morning on cbs, you listed several reasons why people may not be getting vaccinated yet. i am wondering if you are making educated guesses or have any data or figures to show why some people are still holding out, especially in the south where rates are relatively low? dr. fauci: jeff, i think that rochelle got kicked out by her computer. jeff: [laughter] well, the important thing is that all americans have the opportunity to get vaccinated and that means we have to give them the opportunity to get vaccinated. but people have questions and it

is important, we answer questions about the safety and effectiveness of the vaccines. we know all three are very effective and safe but we needed to answer those questions. the good news is that confidence in the vaccines has grown across time as people have neighbors and friends and faith leaders and doctors who have been vaccinated and advise them. the important thing is that the most trusted messengers are trusted doctors and faith leaders. we need to answer the questions that people have and we are confident that more and more people will get vaccinated leading up to the fourth of july. should we try to do one more question, kevin? >> i think we have to wrap up, but thank you, jeff. ♪ >> c-span's washington journal. every day, we take your calls live on the air on the news of the day and discussed policy

issues that impact you. coming up friday morning, a discussion up proposals to forgive student loan debts with jonathan butcher and ashley harrington and people talk about the pandemic's effect on mental health. watch c-spans washington journal live at 7:00 eastern and be sure to join the conversation. ♪ >> american history tv on c-span3, exploring the people and events that tell the american story every weekend. saturday at 8:00 eastern, on lectures in history, the former defense secretary's lecture on the war on terrorism from south carolina. sunday at 6:00 eastern, on

american artifacts, a tour of the smithsonian institution castle. sunday night at 8:00, first ladies. exploring the american story, watch american history tv this weekend on c-span3. ♪ >> on sunday, a military historian and journalist will be our guest on in-depth. >> it inflicted humiliation up on the planet's most powerful nation. revolutionaries prevail over hard work. on the evening of the two the ninth of april, fugitives ascended to a rooftop helicopter , secured the place among symbolic images. for me, the struggle was among the foremost experiences of our

careers. i was one of those who flew out of the u.s. embassy on that day. >>'s most recent book is the soon to be released operation pedestal. other books include catastrophe 1914, chastise, and overlord. join in the conversation with your phone calls, facebook comments, texts, and tweets on in-depth, live at noon eastern, sunday with max hastings on book tv on c-span 2 and visit c-span shop.org to get your copies of books from our featured authors. ♪

>> earlier today, secretary lloyd austin and israeli benny gantz gave brief remarks to the press at the pentagon before a closed-door meeting. -- israeli prime minister -- israeli minister benny gantz gave brief remarks to the press at the pentagon before a closed-door meeting. >> is a pleasure to host you here at the pentagon. i appreciated your hospitality when we saw each other ahead of israel's remembrance day and i